Marex Group President Sells Shares in Routine Transaction
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 07 2026
0mins
Should l Buy MRX?
Source: NASDAQ.COM
- Sale Overview: On April 1, 2026, Marex Group President Simon Van Den Born sold 13,264 shares for approximately $577,000, representing 0.86% of his direct holdings, leaving him with 1,522,229 shares, which indicates his continued confidence in the company.
- Trading Plan Context: The sale was executed under a pre-established Rule 10b5-1 trading plan set by Van Den Born in December 2025, suggesting that the transaction was planned in advance and not a reaction to current company events, alleviating market concerns about his motives.
- Historical Trading Pattern: Van Den Born has sold 14,000 shares on the first trading day of each of the past three months, and the April sale of 13,264 shares is slightly below his recent average, indicating a routine approach to portfolio management rather than a sign of diminishing confidence.
- Company Performance Outlook: Marex Group recently issued strong guidance for Q1 2026, projecting revenues between $667 million and $697 million, reflecting a year-over-year increase of approximately 43% to 49%, which provides robust support for the company's long-term growth and further solidifies investor confidence.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MRX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MRX
Wall Street analysts forecast MRX stock price to fall
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 51.460
Low
49.00
Averages
51.00
High
54.00
Current: 51.460
Low
49.00
Averages
51.00
High
54.00
About MRX
Marex Group plc offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. Its segments include Clearing, Agency and Execution, Market Making, Hedging and Investment Solutions, and Corporate. The Clearing segment acts as the interface between exchanges and clients. This segment provides the connectivity that allows its clients access to exchanges and central clearing houses. The Agency and Execution segment matches buyers and sellers on an agency basis by facilitating price discovery primarily across energy and financial securities markets. Market Making segment acts as principal to provide direct market pricing to professional and wholesale counterparties, primarily metals, agriculture, energy, and financial securities markets. The Company also owns an equity market maker Winterflood Securities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Marex Group Prices $500 Million Senior Notes Offering at 5.68%
- Offering Pricing: Marex Group has successfully priced its public offering of $500 million in Senior Notes at a 5.68% interest rate, issued at 100% of principal as senior unsecured obligations, indicating strong market confidence in its financing needs.
- Clear Use of Proceeds: The net proceeds from this offering will be utilized for working capital and other general corporate purposes, demonstrating Marex's strategic intent to optimize its capital structure and support ongoing business operations.
- Issuance Timeline: The offering is set to close on or about April 21, ensuring timely access to funds to meet the company's financial requirements and further enhance its competitive position in the market.
- Positive Market Reaction: Marex shares gained 1.05% in pre-market trading, reaching $52.00, reflecting investor confidence in the company's future prospects, despite a 1.10% decline in the previous trading session.
See More
Marex Group Receives Positive Ratings from Multiple Firms
- Coverage Resumed with Price Target Increase: On April 8, 2026, Keefe Bruyette resumed coverage on Marex Group with an Outperform rating and a $60 price target, indicating confidence in the stock's potential amidst AI-related concerns and geopolitical pressures, suggesting it remains a viable investment opportunity.
- UBS Raises Price Target: On April 2, 2026, UBS increased its price target for Marex Group from $56 to $60 while maintaining a Buy rating, as insights from CEO Ian Lowitt pointed to additional growth opportunities, leading to an upward revision of revenue growth outlook from 10%-15% to 15%-20%, reflecting strong growth potential.
- Barclays Optimistic on Future Performance: On March 27, 2026, Barclays raised its price target for Marex Group from $50 to $55 and maintained an Overweight rating, with management expressing confidence during investor day, highlighting multiple growth opportunities and potential margin upside from AI, while preliminary Q1 estimates appeared ahead of expectations.
- Strong Financial Outlook: On March 26, 2026, Marex Group projected Q1 adjusted profit before tax of $140M-$150M, representing a year-over-year increase of 45%-55%, driven by elevated market volatility and average clearing client balances of approximately $16B, showcasing the company's resilience in uncertain market conditions.
See More
Marex Group President Sells Shares in Routine Transaction
- Sale Overview: On April 1, 2026, Marex Group President Simon Van Den Born sold 13,264 shares for approximately $577,000, representing 0.86% of his direct holdings, leaving him with 1,522,229 shares, which indicates his continued confidence in the company.
- Trading Plan Context: The sale was executed under a pre-established Rule 10b5-1 trading plan set by Van Den Born in December 2025, suggesting that the transaction was planned in advance and not a reaction to current company events, alleviating market concerns about his motives.
- Historical Trading Pattern: Van Den Born has sold 14,000 shares on the first trading day of each of the past three months, and the April sale of 13,264 shares is slightly below his recent average, indicating a routine approach to portfolio management rather than a sign of diminishing confidence.
- Company Performance Outlook: Marex Group recently issued strong guidance for Q1 2026, projecting revenues between $667 million and $697 million, reflecting a year-over-year increase of approximately 43% to 49%, which provides robust support for the company's long-term growth and further solidifies investor confidence.
See More
Analysis of Marex Group Executive's Share Sale
- Transaction Overview: Marex Group President Simon Van Den Born sold 13,264 shares on April 1, 2026, for approximately $577,000, retaining 1,522,229 shares valued at about $70.1 million post-sale, indicating his continued confidence in the company.
- Trading Pattern: The sale was executed under a pre-established Rule 10b5-1 trading plan set up in December 2025, indicating that this transaction was planned in advance and not a reaction to current company conditions, aligning with his previous monthly sales of 14,000 shares.
- Holding Proportion Analysis: The sale represented 0.86% of Van Den Born's direct holdings, demonstrating that he retains the vast majority of his shares, reflecting his long-term confidence and commitment to Marex Group.
- Company Outlook: Marex Group recently issued strong guidance for Q1 2026, projecting revenues between $667 million and $697 million, representing a year-over-year increase of approximately 43% to 49%, laying a solid foundation for future growth.
See More
MAREX GROUP PLC: BARCLAYS INCREASES TARGET PRICE FROM $50 TO $55
Company Update: Marex Group PLC has received a revised target price from Barclays.
Target Price Increase: Barclays has raised the target price for Marex Group PLC to $55 from the previous $50.
See More
Marex Group Reports Significant Yearly Profit Surge
- Significant Profit Growth: Marex Group reported a pre-tax profit of $411.6 million, up 39% from $295.8 million last year, indicating strong profitability improvements that bolster investor confidence.
- Earnings Per Share Increase: Basic earnings per share rose to $4.12, a 39% increase year-over-year, while adjusted earnings per share reached $4.26, showcasing the company's success in cost control and efficiency improvements, further solidifying its market position.
- Revenue Surge: Full-year revenue climbed 27% to $2.024 billion from $1.595 billion last year, demonstrating the company's effective response to market demand and sales strategies, driving overall performance improvements.
- Positive Stock Reaction: In pre-market trading, Marex Group shares gained 1.60%, reaching $39.48, reflecting the market's positive response to the earnings report, which may attract more investor interest.
See More
Marex Group Prices $500 Million Senior Notes Offering at 5.68%
- Offering Pricing: Marex Group has successfully priced its public offering of $500 million in Senior Notes at a 5.68% interest rate, issued at 100% of principal as senior unsecured obligations, indicating strong market confidence in its financing needs.
- Clear Use of Proceeds: The net proceeds from this offering will be utilized for working capital and other general corporate purposes, demonstrating Marex's strategic intent to optimize its capital structure and support ongoing business operations.
- Issuance Timeline: The offering is set to close on or about April 21, ensuring timely access to funds to meet the company's financial requirements and further enhance its competitive position in the market.
- Positive Market Reaction: Marex shares gained 1.05% in pre-market trading, reaching $52.00, reflecting investor confidence in the company's future prospects, despite a 1.10% decline in the previous trading session.
See More
Marex Group Receives Positive Ratings from Multiple Firms
- Coverage Resumed with Price Target Increase: On April 8, 2026, Keefe Bruyette resumed coverage on Marex Group with an Outperform rating and a $60 price target, indicating confidence in the stock's potential amidst AI-related concerns and geopolitical pressures, suggesting it remains a viable investment opportunity.
- UBS Raises Price Target: On April 2, 2026, UBS increased its price target for Marex Group from $56 to $60 while maintaining a Buy rating, as insights from CEO Ian Lowitt pointed to additional growth opportunities, leading to an upward revision of revenue growth outlook from 10%-15% to 15%-20%, reflecting strong growth potential.
- Barclays Optimistic on Future Performance: On March 27, 2026, Barclays raised its price target for Marex Group from $50 to $55 and maintained an Overweight rating, with management expressing confidence during investor day, highlighting multiple growth opportunities and potential margin upside from AI, while preliminary Q1 estimates appeared ahead of expectations.
- Strong Financial Outlook: On March 26, 2026, Marex Group projected Q1 adjusted profit before tax of $140M-$150M, representing a year-over-year increase of 45%-55%, driven by elevated market volatility and average clearing client balances of approximately $16B, showcasing the company's resilience in uncertain market conditions.
See More
Marex Group President Sells Shares in Routine Transaction
- Sale Overview: On April 1, 2026, Marex Group President Simon Van Den Born sold 13,264 shares for approximately $577,000, representing 0.86% of his direct holdings, leaving him with 1,522,229 shares, which indicates his continued confidence in the company.
- Trading Plan Context: The sale was executed under a pre-established Rule 10b5-1 trading plan set by Van Den Born in December 2025, suggesting that the transaction was planned in advance and not a reaction to current company events, alleviating market concerns about his motives.
- Historical Trading Pattern: Van Den Born has sold 14,000 shares on the first trading day of each of the past three months, and the April sale of 13,264 shares is slightly below his recent average, indicating a routine approach to portfolio management rather than a sign of diminishing confidence.
- Company Performance Outlook: Marex Group recently issued strong guidance for Q1 2026, projecting revenues between $667 million and $697 million, reflecting a year-over-year increase of approximately 43% to 49%, which provides robust support for the company's long-term growth and further solidifies investor confidence.
See More
Analysis of Marex Group Executive's Share Sale
- Transaction Overview: Marex Group President Simon Van Den Born sold 13,264 shares on April 1, 2026, for approximately $577,000, retaining 1,522,229 shares valued at about $70.1 million post-sale, indicating his continued confidence in the company.
- Trading Pattern: The sale was executed under a pre-established Rule 10b5-1 trading plan set up in December 2025, indicating that this transaction was planned in advance and not a reaction to current company conditions, aligning with his previous monthly sales of 14,000 shares.
- Holding Proportion Analysis: The sale represented 0.86% of Van Den Born's direct holdings, demonstrating that he retains the vast majority of his shares, reflecting his long-term confidence and commitment to Marex Group.
- Company Outlook: Marex Group recently issued strong guidance for Q1 2026, projecting revenues between $667 million and $697 million, representing a year-over-year increase of approximately 43% to 49%, laying a solid foundation for future growth.
See More
MAREX GROUP PLC: BARCLAYS INCREASES TARGET PRICE FROM $50 TO $55
Company Update: Marex Group PLC has received a revised target price from Barclays.
Target Price Increase: Barclays has raised the target price for Marex Group PLC to $55 from the previous $50.
See More
Marex Group Reports Significant Yearly Profit Surge
- Significant Profit Growth: Marex Group reported a pre-tax profit of $411.6 million, up 39% from $295.8 million last year, indicating strong profitability improvements that bolster investor confidence.
- Earnings Per Share Increase: Basic earnings per share rose to $4.12, a 39% increase year-over-year, while adjusted earnings per share reached $4.26, showcasing the company's success in cost control and efficiency improvements, further solidifying its market position.
- Revenue Surge: Full-year revenue climbed 27% to $2.024 billion from $1.595 billion last year, demonstrating the company's effective response to market demand and sales strategies, driving overall performance improvements.
- Positive Stock Reaction: In pre-market trading, Marex Group shares gained 1.60%, reaching $39.48, reflecting the market's positive response to the earnings report, which may attract more investor interest.
See More
